Search
Cartesian Therapeutics Inc
RNACAdd to Watchlist
10.590USD
+0.410+4.03%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
275.38MMarket Cap
LossP/E TTM
Cartesian Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Cartesian Therapeutics Inc is 8.32, ranking 152 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.83, which is -12788.51% below the recent high of 232.00 and -17773.41% above the recent low of -326.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.